Home › Fabry Disease › Minnesota › Minneapolis
Fabry Disease clinical trials in Minneapolis, MN
5 studies for Fabry Disease are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
RecruitingPhase 3
- The University of Minnesota, Fairview Health, Minneapolis
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
RecruitingPhase 3
- University of Minnesota Masonic Children's Hospital, Minneapolis
Fabry Disease Registry & Pregnancy Sub-registry
RecruitingObservational study
- Children's Hospitals and Clinics of Minnesota- Site Number : 840114, Minneapolis
- M Health Fairview University of Minnesota Medical Center - West Bank- Site Number : 840076, Minneapolis
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
RecruitingPhase 1/2
- MHealth Fairview University of Minnesota Medical Center East Bank, Minneapolis
Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
RecruitingObservational study
- University of Minnesota, Minneapolis
- Universtity of Minnesota, Department of Pediatric Nephrology, Minneapolis
Fabry Disease trials in other cities
- Atlanta, GA7 studies
- Arlington, VA6 studies
- Birmingham, AL5 studies
- Cincinnati, OH4 studies
- Pittsburgh, PA4 studies
- Chicago, IL4 studies
- Salt Lake City, UT3 studies
- Cedar Rapids, IA3 studies
- Dallas, TX3 studies
- New York City, NY3 studies
- Philadelphia, PA3 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.